Financhill
Back

Humacyte 10K Form

Buy
71

HUMA
Humacyte

Last Price:
6.33
Seasonality Move:
-9.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HUMA News And Ratings

See the #1 stock for the next 7 days that we like better than HUMA

HUMA Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-27.74M
Price / Cash Flow: 0
Annual Sales: $0.22
Price / Book: 28.82

Profitability

EPS (TTM): -1.00000
Net Income (TTM): $-105.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Humacyte Earnings Forecast

Key Humacyte Financial Ratios

  • The Interest Expense is -5.96% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Humacyte Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HUMA
Website: humacyte.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HUMA Technical Analysis vs Fundamental Analysis

Buy
71
Humacyte (HUMA) is a Buy

Is Humacyte a Buy or a Sell?

  • Humacyte stock is rated a Buy
    The current Humacyte [HUMA] share price is $6.33. The Score for HUMA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.